244 results on '"Lanteri, Marion C."'
Search Results
2. Detection of anti-nucleocapsid antibodies associated with primary SARS-CoV-2 infection in unvaccinated and vaccinated blood donors
3. Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study
4. Frequent blood donations alter susceptibility of red blood cells to storage‐ and stress‐induced hemolysis
5. Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status--United States, April 2021-September 2022
6. Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction
7. End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral.
8. Syphilis seroprevalence and incidence in US blood donors from 2020 to 2022.
9. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome
10. Soluble T Cell Immunoglobulin Mucin Domain 3 Is Shed from CD8+ T Cells by the Sheddase ADAM10, Is Increased in Plasma during Untreated HIV Infection, and Correlates with HIV Disease Progression
11. Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers
12. Zika virus in French Polynesia 2013–14: anatomy of a completed outbreak
13. An update on Zika virus infection
14. Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage
15. Plasma transfusion–transmission of Zika virus in mice and macaques
16. Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients
17. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses
18. Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction
19. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione
20. Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione
21. Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak
22. Thoughts Around the Zika Virus Crisis
23. Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
24. Quantitative restoration of immune defense in old animals determined by naive antigen‐specific CD8 T‐cell numbers
25. Amustaline (S‐303) treatment inactivates high levels of Zika virus in red blood cell components
26. Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real‐time polymerase chain reaction assays for detection of Zika virus RNA
27. Interferon and Interferon-Induced Chemokine Expression Is Associated with Control of Acute Viremia in West Nile Virus–Infected Blood Donors
28. Comprehensive Analysis of West Nile Virus-Specific T Cell Responses in Humans
29. Quantitative Restoration of Immune Defense in Old Animals Determined by Naïve Antigen-Specific CD8 T cell Numbers
30. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety
31. Tregs control the development of symptomatic West Nile virus infection in humans and mice
32. Sepsis from an apheresis platelet contaminated withAcinetobacter calcoaceticus/baumanniicomplex bacteria andStaphylococcus saprophyticusafter pathogen reduction
33. Dengue in the context of “safe blood” and global epidemiology: to screen or not to screen?
34. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
35. Inactivation ofPlasmodium falciparumin whole blood using the amustaline and glutathione pathogen reduction technology
36. Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
37. Corrigendum to: Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction
38. Differential Pattern of Soluble Immune Markers in Asymptomatic Dengue, West Nile and Zika Virus Infections
39. Progress towards an appropriate pathogen reduction technology for whole blood in Africa
40. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses
41. In vitro evaluation of pathogen inactivated platelet quality: An 8 year experience of routine use in Galicia, Spain
42. Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction.
43. Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology.
44. Progress towards an appropriate pathogen reduction technology for whole blood in Africa.
45. Inactivation des arbovirus dans les produits sanguins labiles
46. Zika virus in Singapore: unanswered questions
47. Documentation of transfusion-transmitted arbovirus infections in endemic areas
48. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination
49. Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study
50. Emergence of Zika virus: where does it come from and where is it going to?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.